Peter Bains has been appointed Group CEO of Biocon
Biocon announced that its Board of Directors has approved the appointment of Peter Bains as Group CEO, effective immediately. He will be indicating directly to Biocon Group chairman Kiran Mazumdar-Shaw. Bains has resigned from his position as an independent director on the Biocon Board with immediate effect to take on this strategic managerial responsibility.
"I am delighted to welcome Peter as Group CEO to the Biocon Group". "Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, CEO & MD Biocon Biologics Limited, and Jonathan Hunt, CEO & MD Syngene International Limited, will retain independent charge of their businesses and will work with Peter to strengthen synergistic strategic leadership at a Group level to maximize the combined value of all three businesses", Mazumdar-Shaw said.
Peter has a unique fit and profile for the role, according to Mazumdar-Shaw, with extensive global leadership experience and success in the biopharmaceutical field, as well as a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, leading it through its very successful IPO in 2015. "I am confident that this appointment will serve the integrated business objectives of the Biocon Group of companies and deliver added value to all stakeholders".
